Boudina Laboratory

About 47 million Americans are living with cardiometabolic diseases such as hypertension, obesity, diabetes, and non-alcoholic fatty liver disease. These conditions often co-exist, increasing the risk of morbidity and mortality. Unfortunately, the development and progression of these diseases is not yet completely understood. The Boudina Lab conducts translational research that contributes to this knowledge gap by studying the molecular mechanisms driving obesity, cardiometabolic disease, and cardiomyopathy with a special emphasis on mitochondrial energetics and autophagy. Our goal is to develop a deeper understanding of the development and progression of cardiometabolic diseases to identify advanced therapeutics to lessen the disease burden on millions of individuals and our society.